Vor Biopharma VOR Institutional Ownership

Updated Oct 11, 2026

Vor Biopharma Inc. (NASDAQ:VOR) was held by 103 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

• Their combined stake equaled 89.08% of outstanding shares in Q2 2026, up from 74.65% in Q1 2026.
• Total holdings of Vor Biopharma shares rose 19.92% from Q1 2026, and the number of holders rose 202.94% from Q2 2025.
• Of the 103 holders of VOR in Q2 2026, 75 added to their positions, 19 reduced their stakes and 9 left their positions unchanged.
• Combined, institutional investors held 48.51Mn shares of VOR as of Q2 2026, up 8.06Mn from the prior quarter and up 45.65Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Vor Biopharma was TCG Crossover Management, LLC with 5.67Mn shares, or 10.42% of shares outstanding.
• Among existing holders, the largest additions to Vor Biopharma in Q2 2026 came from FMR LLC (+3.39Mn shares), BlackRock, Inc. (+2.67Mn shares), State Street Corp (+1.5Mn shares), Geode Capital Management, LLC (+719.9K shares) and Vanguard Capital Management LLC (+651.05K shares).
• On the other side, among holders that kept a position in Vor Biopharma, the largest reductions in Q2 2026 came from Ra Capital Management, L.P. (-3Mn shares), Marshall Wace, LLP (-1.06Mn shares), Susquehanna International Group, LLP (-216.15K shares), Tudor Investment Corp (-132.95K shares) and NEXTBio Capital Management LP (-110.8K shares).
• According to Business Quant data, the leading holders of VOR for Q2 2026 were TCG Crossover Management, LLC (5.67Mn shares), FMR LLC (4.93Mn shares), FCPM III Services B.V. (4.12Mn shares), BlackRock, Inc. (3.47Mn shares), Venrock Adviser, LLC (3.04Mn shares), State Street Corp (2.62Mn shares), Frazier Life Sciences Management, L.P. (2.54Mn shares), Ra Capital Management, L.P. (2.4Mn shares), Vanguard Capital Management LLC (2.08Mn shares) and Caligan Partners LP (1.93Mn shares).